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the knee at 3, 7, 14, 28, 56, 84, 112 days (n 8 per group). Changes in
subchondral bone at 28 days post DMM (n ¼ 6) were measured sepa-
rating the subchondral plate from the subchondral tabecular structures.
Results: Osteophytes were identiﬁed in 70% of mice by day 7 post DMM
and in all mice by day 14. At day 7 most samples had 1 or 2 osteophytes,
with somehavingup to 4 osteophytes by day 14. Fromday 28onwards the
osteophytes fused and formed into one or two large osteophytes. Osteo-
phytes increased in size and bone content with time, plateauing by day
112. The trabeculae of the subchondral bone at day 28 showed a sig-
niﬁcant (p<0.03) decrease in trabecular number on the medial side of
both theDMMand shamoperatedmicewhen compared to the respective
contralateral leg. In the sham samples, the reduction of trabecular num-
ber translated to a signiﬁcant increase in trabecular space, whereas in the
DMMmice an increase in trabecular thickness occurred, eliminating the
increase in trabecular space. Although bone changes occurred within a
week of DMM induction, cartilage damage scores were not signiﬁcant
until day 56 (p<0.05), compared to earlier time points.
Conclusions:We herein charachterised differential bone changes in the
DMM murine model of OA: there was accelerated osteophyte devel-
opment within the ﬁrst week, whereas subchondral bone changes were
not evident until day 28. Interestingly sham operated animals showed
subchondral trabecular bone loss in the ipsilateral knee, highlighting
the need to use the contralateral knee as an internal control. The early
bone changes in this OA model signiﬁcantly preceded cartilage degra-
dation, consistent with altered bone biology being an important driver
of OA pathogenesis.Supported By Arthritis Research UK (20199).
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PPARDELTA PROMOTES THE PROGRESSION OF POST-TRAUMATIC
OSTEOARTHRITIS
A. Ratneswaran y, E. LeBlanc y, E. Walser y, I. Welch y, J.S. Mort z,x,
N. Borradaile y, F. Beier y,k. yWestern Univ., London, ON, Canada; zMcGill
Univ., Montreal, QC, Canada; x Shriner’s Hosp. for Children, Montreal, ON,
Canada; k Children’s Hlth.Res. Inst., London, ON, Canada
Background: Osteoarthritis (OA) is a degenerative joint disorder,
characterized by the breakdown of articular cartilage, subchondral bone
thickening, osteophyte formation and synovial inﬂammation. The
human burden of this disease inﬂuences both the independence and
quality of life of those afﬂicted. Currently, there are no pharmaceutical
treatments to slow, stop or reverse disease progression, resulting in
greatly reduced quality of life for OA patients and the need for joint
replacement surgeries in many cases. The lack of available treatments
for OA is partially due to our incomplete understanding of themolecular
mechanisms promoting disease initiation and progression. Recent
ﬁndings from our laboratory indicate that activation of the transcription
factor PPARdelta induces the expression of enzymes involved in pro-
teoglycan breakdown and can lead to cartilage degeneration in OA,
prompting us to speculate whether inhibition of PPARdelta, can protect
from cartilage breakdown in OA.
Purpose:We aimed to characterize the role of PPARdelta in OA through
in-vitro, ex-vivo, and in-vivo studies to determine whether it is a fea-
sible target for OA therapy.
Hypothesis: We hypothesize that inhibition of PPARdelta will slow the
progression of OA in animal models.
Methods: Primary mouse chondrocytes and cartilage explants were
treated with a pharmacological PPARdelta agonist (GW501516) to
evaluate changes in gene expression (qPCR), and histology (Safranin-O,
immunohistochemistry) consistent with OA development. In order to
examine the role of PPARdelta in-vivo, cartilage-speciﬁc knockout mice
and wild-type littermate controls were subjected to destabilization of
medial meniscus surgery (DMM) at 20 weeks of age. 8 weeks post-
surgery mice were compared through classical histological and bio-
chemical measures of OA progression including Safranin-O staining
with OARSI scoring, immunohistochemistry for cartilage matrix
breakdown products, and picrosirius red staining for collagen ﬁber
structure and orientation.
Results: In vitro, PPARdelta agonism (by GW501516) results in the
upregulation of expression of proteases implicated in cartilage degen-
eration (including MMPs, and ADAMTS genes). Activation of PPARdelta
also results in proteoglycan breakdown in the cartilage matrix of an
explant culture system. Mice with cartilage-speciﬁc deletion of PPAR-
delta do not demonstrate any abnormalities in skeletal growth or
development, but do show signiﬁcant chondroprotection in comparisonto wild-type littermate controls after surgical induction of OA. OARSI
scoring and immunohistochemistry conﬁrm strong protection of
mutant mice against cartilage matrix breakdown, and decreased
breakdown products in the cartilage of PPARdelta knockout mice.
Conclusion: This study provides strong evidence for catabolic roles of
endogenous PPARdelta in post-traumatic OA and suggests that phar-
macological inhibition of PPARdelta is a promising therapeutic strategy.
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DKK3 PREVENTS MATRIX LOSS INDUCED BY PRO-INFLAMMATORY
CYTOKINES IN HUMAN CARTILAGE EXPLANTS
S.M. Walzer, D. Bieder, B. Simon, R. Windhager, S. Toegel. Karl Chiari Lab
for Orthopaedic Biology, Dept. of Orthopaedics, Med. Univ. of Vienna,
Vienna, Australia
Purpose: Osteoarthritis (OA) is a prevalent disease with high socio-
economic impact characterized by loss of articular cartilage. High-
lighted by a number of genetic and cell biology studies, the interception
of cell signaling pathways imply an important mechanism in OA
development and pathogenesis. Dkk3 is a member of the Dickkopf
family of WNT antagonists which is recently recognised to be upregu-
lated in OA cartilage. In the pathogenesis of OA the WNT signaling
pathway plays a role but the function of DKK3 in inﬂammation of joints
is still poorly described. According to recent reports the activation of
WNT signaling leads to an upregulation of TNF-a. In our study we
investigated the response of DKK3 in human OA cartilage explants to
the pro-inﬂammatory cytokines IL1-b and TNF-a.
Methods: Osteochondral explants (5mm) were created from human
femoral condyles (n ¼ 3 donors) of OA patients. The explants were
treated in duplicates with 10ng/ml IL1-b, 10ng/ml TNF-a and 10ng/ml
IL1-b þ 10ng/ml TNF-a for 21 days. Controls were left untreated. The
medium was collected for GAG analysis. Safranin-O stained parafﬁn
sections (2.5 mm) of the explants were assessed by Mankin score. The
release of glycosaminoglycans (GAG) from explants into the culture
medium was measured based on 1,9-dimethylmethylene blue binding.
For immunolabeling, explants were incubatedwithmonoclonal antibody
Dkk3 to determine whether an elevation in Dkk3 presence was asso-
ciated with the activation of TNF-a and IL1-b. Parafﬁn embedded 2.5mm
sections were deparafﬁnized and blocked with 10% donkey serum for 30
min, and incubated incubated overnight at 4C with antibodies against
Dkk3 in a dilution of 1:100 in 0.05 M Tris Buffer. After washing the slides
with TBS, the secondary antibody alexa ﬂuor 488 was applied for one
hour at room temperature containing 10mM 40,6-diamidino-2-phenyl-
indole (DAPI) for nuclear staining. The slides were observed under a
confocal laser scanning microscope connected to a digital imaging sys-
tem. Negative controls leaving the primary antibody were prepared. To
identify the ability of Dkk3 to reduce the activity of pro-inﬂammatory
cytokines on matrix loss, we incubated cartilages explants with 10ng/ml
recombinant human Dkk3 prior to IL1-b and TNF-a.
Results: Osteochondral explants show an increased loss of GAG and
differences in the Mankin score by the use of pro-inﬂammatory cyto-
kines IL1-b and TNF-a. Immunoﬂuorescence analysis using Dkk3 anti-
body showed that TNF-a/IL1-b treatment (10ng/ml, 21 days) promoted
an increased occurrence of Dkk3þ chondrocytes mainly in the surface
and superﬁcial zone of the cartilage fraction of the explants and lacking
positive staining in the deep zone compared to control. Treatment with
Dkk3 prior to IL1-b and TNF-a indicate a decreased GAG loss in explants.
Conclusions: The regulation of signaling in the pathogenesis of OA is
subjected to several parameters which inﬂuence also the balance and
activity of pro-inﬂammatory factors in joints. The appearance of Dkk3
protein is increased in OA and modiﬁed by IL1-b and TNF-a. Our data
shows the protective role of Dkk3 by its ability to decrease the loss of
matrix in the presence of IL1-b and TNF-a.
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RELATIONSHIP BETWEEN SUBCHONDRAL BONE CYSTS, THE
SEVERITY OF KNEE OSTEOARTHRITIS, AND ALIGNMENTS OF
LOWER EXTREMITIES
N. Okazaki y, K. Chiba z, K. Kidera z, A. Yonekura z, M. Osaki z. yUniv. of
California, San Francisco, San francisco, CA, USA; zNagasaki Univ.,
Nagasaki, Japan
Purpose: To evaluate the characteristics of the subchondral bone cysts
(SBCs) in osteoarthritis (OA) of the knee.
a These authors contributed equally to this work.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S371Methods: Subjects were 29 patients (53 knees) with knee OA (mean age
65.3  9.8, range 50 – 80 years, all female, Kellgren-Lawrence (KL)
grades II: 23, III: 12, IV: 18). The anteroposterior radiographs of lower
extremities in standing position and the CT images of knee joints were
all prepared. Femorotibial (FT) joint was divided into 5 regions: medial
femoral condyle (MFC), medial tibial plateau (MTP), lateral femoral
condyle (LFC), lateral tibial plateau (LTP) and subspinous (SS). The
location, number, and size of SBCs were measured in CT. SBCs were
deﬁned as the cysts greater than 2 mm in diameter, occurring in the
region within 10 mm from the joint surface. The alignments of lower
extremity were measured in radiographs: percentage of mechanical
axis (%MA), femorotibial angle (FTA), lateral distal femoral angle (LDFA),
medial proximal tibial angle (MPTA), and joint line convergence angle
(JLCA). Relationship between the number of SBCs and the severity of OA
or alignments of lower extremity was analyzed.
Results: SBCs were detected in 88.5% of knees, 53.8% in MFC; 51.9% in
MTP; 5.8% in LFC; 13.5% in LTP; and 17.3% in SS. The mean number of
SBCs was 2.5 in MFC; 2.1 in MTP; 3.0 in LFC; 1.2 in LTP; 1.6 in SS. The
mean size of SBCs resulted respectively as follows: 2.9 mm in MFC; 3.6
mm inMTP; 3.8 mm in LFC; 3.0 mm in LTP, 5.2 mm in SS. The number of
SBCs in MFC and MTP had a signiﬁcantly positive correlation with KL
grades, FTA and JLCA, and had a signiﬁcantly negative correlationwith %
MA and MPTA. However, there was no correlation in LFC, LTP and SS.
Conclusions: SBCs were frequently detected in patients with knee OA,
and more prevalent in medial FT joint. The incidence in medial FT joint
was affected by the severity of knee OA or varus knee deformity,
although the mean size was small and the number was few. However,
SBCs were present in lateral FT joint and SS, and these were not affected
by the severity of knee OA or varus knee deformity.
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THE ASSOCIATION OF BODY COMPOSITION AND METABOLIC
SYNDROME WITH KNEE OA AND KNEE PAIN IN A KOREAN
COMMUNITY RESIDENTS
H. Kim. Div of Rhematology, Hallym Univeristy Sacred Heart Hosp.,
Anyang, Republic of Korea
Objectives: Obesity, a major concern of contemporary health care sys-
tem is closely related to both musculoskeletal pain and OA. Recently,
proinﬂammatory effect of obesity, independent of its biomechanical
effect has also been gaining interest in the pathogenesis of OA. In this
study, we sought to delineate the relationship between body compo-
sition parameters and knee OA/knee pain in a Korean community res-
idents. In addition, we tried to examine the inﬂuence of metabolic
syndrome on knee OA/knee pain independent of BMI by assessing the
risk stratiﬁed by body mass index (BMI) and the presence or absence of
metabolic syndrome (MetS)
Methods: Participants were from the population-based Hallym Aging
Study, irrespective of the presence of knee OA or knee pain. Demo-
graphic data was obtained by questionnaire. Knee pain was assessed
using the Western Ontario and McMaster Universities (WOMAC)
Osteoarthritis Index and a 100-mm visual analog scale (VAS). Radio-
graphic evaluations consisted of weight-bearing knee anteroposterior
radiographs. Total body fat mass and total lean mass were measured
with Dual x-ray absorptiometry. Each subject underwent MRI of the
more symptomatic knee or the dominant knee depending on the
symptom presence. MRI scans of the knee were obtained with a 1.5-T
scanner with a phase-array knee coil and were read according to
WORMS grading system.
Result: The mean age of participants (230 men, 274 women) was 70.2
years. Radiographic knee OAwas present in 37.3% of subjects. BMI, total
fat mass, and fat/muscle ratio were all signiﬁcantly and positively cor-
related with knee OA while total lean mass was signiﬁcantly and neg-
atively correlated with it. After adjusting for age, sex, and manual work,
the association remained signiﬁcant only for fat/muscle ratio. The
association between fat/muscle ratio and pain VAS score was signiﬁcant
after adjustment. To analyze the association between metabolic syn-
drome features independent of body mass index, we divided the pop-
ulation into 4 groups, (metabolically non-obese, normal weight
(MNNW), metabolically obese, normal weight (MONW), metabolically
non-obese, obese (MNOB), and metabolically obese, obese(MOOB). ORs
for knee OA was signiﬁcantly higher only among MOOB compared to
MNNWafter adjustment. The severity of knee painwas not signiﬁcantly
associated with any of the 3 subgroups compared to MNNW. Cartilage
degeneration as measured with MRI was signiﬁcantly associated onlyfor BMI after adjustment, and was not signiﬁcantly associated with any
of the 3 subgroups compared to MNNW. Neither any component of the
metabolic syndrome, nor the number of metabolic component was
signiﬁcantly associated with radiographic knee OA, knee pain, or car-
tilage degeneration measured with MR.
Conclusion: These results suggest that aside from BMI, body compo-
sition, speciﬁcally fat/muscle mass ratio may have important implica-
tions for the pathogenesis of knee OA and knee pain, while metabolic
syndrome may not.
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ANCIENT CHINESE MEDICINE BASED ON A LECTIN (MASL), THAT
TARGETS GLYCOPROTEINS CONTAINING ALPHA-2-3-SIALIC ACID
RESIDUES, DECREASES PROINFLAMMATORY MEDIATORS
PRODUCTION AND EXTRACELLULAR MATRIX DEGRADATION
RESPONSE IN ARTICULAR CARTILAGE
M.D. Mayan y,a, P. Carpintero-Fernandez y,a, R. Gago-Fuentes y,
G.S. Goldberg z, F.J. Blanco k,x. yCartilage Biology Res. Group.
Rheumatology Div. INIBIC-Hosp. Univ. rio A Coru~na, A Coru~na, Spain;
zDept. of Molecular Biology, Med. Ctr. Drive, Univ. of Med. and Dentistry
of New Jersey, Stratford, NJ, USA; x ProteoRed/ISCIII, Proteomics Group,
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Purpose: Glycosylated proteins are essential components of the extrac-
ellular matrix (ECM) of cartilage and contribute to the maintenance of its
function. A shift from a-2,6- to a-2,3-linked sialic acids of glycoproteins
modiﬁes the binding ability of proteins to substrates inﬂuencing cellular
anchoring and affecting signal transduction. Intriguingly, the predom-
inance of a-2,3-sialylation of chondrocytes glycoproteins was associated
with the pathophysiology of rheumatic diseases including rheumatoid
arthritis (RA) and osteoarthritis (OA). A highly O-glycosylated protein
with a-2,3-sialic acid, involved in the induction of inﬂammation and
tissue repair, is the transmembrane mucin receptor named Podoplanin
(PDPN). The present studyaimed to assess the effect of speciﬁcally targets
a-2-3-sialic acid residues with a lectin-based drug (MASL) on chon-
drocyte dedifferentiation and cartilage breakdown processes.
Methods: For immunoﬂuorescence and immunohistochemistry assays,
in situ cartilage was ﬁxed and frozen immediately using Tissue-Tek O.C.T.
and isopentanol in liquid nitrogen. Primary cells in monolayer culture
were ﬁxed with formaldehyde for optical microscopy assays. 4 mm car-
tilage puncheswere prepared from cartilage explants thatwere cut in the
operating room immediately after surgery and cultured in DMEM with
0.1% FCS. Chondrocyteswere isolated fromarticular cartilage and cultured
in DMEM with 15% FCS. Cell viability was evaluated by the colorimetric
MTT assay. Cell adhesion and grown was assess with ﬁbrinogen-coated
well plates and Wound Healing Assay Kit. Reactive oxygen species levels
were measured by DCFH-DA and by Flow Cytometry. RNA was isolated
with TRIZOL Reagent and analyzed by Real-Time RT-PCR.
Results: The treatment of chondrocytes with 400 and 720 nM of MASL
did not affect cell viability, adhesion or growth. To mimic pathological
conditions, cells and cartilage explants were treated with 5 mg/ml oli-
gomycin. Treatment of chondrocytes with oligomycin did not affect cell
viability but increased ROS levels over 10 fold andMMP3, IL-6 and COX2
mRNA levels over 3–10 folds. The treatment of cells with MASL effec-
tively protected chondrocytes from ROS production when incubated in
the presence of oligomycin. Moreover, oligomycin induced the expres-
sion of inﬂammatory cytokines including IL-6 and COX2, and this
induction was reverted by treatment with nanomolar concentrations of
MASL. 5 mg/ml of oligomycin for 7 days decreased safranin uptake and
disrupted the ECM structure of cartilage punches as evidenced by
ulceration increasing lacunae space. However, the presence of 400 nM
of MASL prevented the cartilage destruction and inhibited COX2 and
MMP3 induction by oligomycin treatment. Immunohistochemistry
assays revealed that OA cartilage contained signiﬁcantly higher levels of
PDPN protein in comparison with cartilage from healthy donors.
Conclusions: This study demonstrates that physiologically relevant
concentrations of MASL protect chondrocytes from detrimental effects
of ROS, inﬂammatory cytokines and MMPs and preserve chondrocyte
phenotype and articular cartilage structure under pathological con-
ditions.
